Evaluation of the Performance and Safety of the Atoldys/ Lexilens Glasses Developed to Improve the Reading of Dyslexic Subjects
Primary Purpose
Dyslexia
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Atoldys/ Lexilens - SHAM
SHAM- Atoldys/ Lexilens
Sponsored by
About this trial
This is an interventional treatment trial for Dyslexia
Eligibility Criteria
Inclusion Criteria:
- Schooled in CM1, CM2 or 6ème,
- French mother tongue,
- For whom developmental dyslexia has been diagnosed by a health professional who specializes in this learning disorder,
- With near vision, without optical correction, equivalent to P5 or better according to the Parinaud scale (distance: 30-40 cm),
- Presenting an IQ ≥ 80 and ≤130 according to the WISC-V test performed by a psychologist,
- For whom a written consent was obtained regarding his study participation.
Exclusion Criteria:
- With medical history or presenting a neurological pathology,
- Presenting a developmental disorder (autism, ADHD, ...),
- Presenting hearing disorders,
- Presenting an astigmatism of more than one uncorrected diopter,
- Presenting other visual disorders,
- Any other condition that, in the opinion of health professionals, could impair its ability to complete the study or could pose a significant risk.
Sites / Locations
- Dr Laurence Derieux
- Dr Luc-Marie Virlet
- CHU Rennes
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Atoldys/ Lexilens - SHAM
SHAM- Atoldys/ Lexilens
Arm Description
Outcomes
Primary Outcome Measures
Reading performance aloud of a text with french E.L.FE Test
E.L.FE Test (=Evaluation de la Lecture en FluencE) - "Monsieur Petit" and "Le Géant égoïste" texts : percentile
Secondary Outcome Measures
Reading performance aloud of isolated words with french BALE Test
BALE test (=Batterie Analytique de Langage Ecrit): percentile
Security: incidence of Adverse Events
By questioning the child & the speech therapist - evaluation of adverse effects due to glasses (Yes/ No): headache, nausea, dizziness, fatigue and eye fatigue. According to patient questioning and clinical exam, the Adverse Event Table will be completed (description, dates, severity, imputability, action,...).
Security: device deficiencies
By questioning the speech therapist - evaluation of deficiencies due to glasses: the device deficienciesTable will be completed (description, relation with adverse effect, taken measures,...).
Child's satisfaction regarding reading fluency and comprehension
Child interview with numeric scale (0-10) and yes/ no answer
Speech therapist's satisfaction regarding Securirty, Performance and Usability of glasses
speech therapist interview with 4 points - Likert scale (Very good, Good, Moderate, Bad)
Full Information
NCT ID
NCT04586621
First Posted
October 7, 2020
Last Updated
February 11, 2022
Sponsor
ABEYE
Collaborators
Slb Pharma
1. Study Identification
Unique Protocol Identification Number
NCT04586621
Brief Title
Evaluation of the Performance and Safety of the Atoldys/ Lexilens Glasses Developed to Improve the Reading of Dyslexic Subjects
Official Title
Evaluation of the Performance and Safety of the Atoldys/ Lexilens Glasses Developed to Improve the Reading of Dyslexic Subjects
Study Type
Interventional
2. Study Status
Record Verification Date
February 2022
Overall Recruitment Status
Completed
Study Start Date
January 19, 2021 (Actual)
Primary Completion Date
June 29, 2021 (Actual)
Study Completion Date
June 29, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
ABEYE
Collaborators
Slb Pharma
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this study is to evaluate the efficacy and safety of a new medical device (Atoldys/ Lexilens glasses) on the improvement of reading skills of young dyslexic subjects.
Detailed Description
Dyslexia is defined as a specific learning disability that is characterized by reading difficulties, in the absence of intellectual disability, neurological or psychiatric disorder, uncorrected sensory disturbance (sight, hearing) or an educational deficiency.
Dyslexia appears in the child from the earliest stages of learning in the form of a difficulty in mastering the learning of reading. This disorder is manifested by a generally hesitant reading, slowed down, full of errors, requiring a lot of effort for the child and may impact his reading comprehension. The dyslexia-related deficiency is of variable intensity depending on the individual; it may be accompanied by calculus disorders (dyscalculia), oral language (dysphasia), motor coordination (dyspraxia) or attention disorders with or without hyperactivity. In nearly 40% of cases, a child affected by Dys disorders presents several learning disorders.
To date, the causes of dyslexia are not yet clearly established. The wide variety of symptoms and disorders associated with dyslexia does not facilitate the identification of precise neurobiological / psycho cognitive mechanisms. There are therefore several theories: phonological, visual, temporal, cerebellar or proprioceptive auditory processing.
Recently, following work published in 2017, an anatomical cause based on Maxwell's spots could also be a cause of dyslexia.
The aim of this study is to evaluate a new medical device (class I CE marked) to compensate this probable anatomical cause: the Atoldys/ Lexilens glasses
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dyslexia
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
41 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Atoldys/ Lexilens - SHAM
Arm Type
Experimental
Arm Title
SHAM- Atoldys/ Lexilens
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
Atoldys/ Lexilens - SHAM
Intervention Description
Atoldys/ Lexilens: glasses with specific light frequency SHAM: glasses with no frequency
Intervention Type
Device
Intervention Name(s)
SHAM- Atoldys/ Lexilens
Intervention Description
SHAM: glasses with no frequency Atoldys/ Lexilens: glasses with specific light frequency
Primary Outcome Measure Information:
Title
Reading performance aloud of a text with french E.L.FE Test
Description
E.L.FE Test (=Evaluation de la Lecture en FluencE) - "Monsieur Petit" and "Le Géant égoïste" texts : percentile
Time Frame
1 day
Secondary Outcome Measure Information:
Title
Reading performance aloud of isolated words with french BALE Test
Description
BALE test (=Batterie Analytique de Langage Ecrit): percentile
Time Frame
1 day
Title
Security: incidence of Adverse Events
Description
By questioning the child & the speech therapist - evaluation of adverse effects due to glasses (Yes/ No): headache, nausea, dizziness, fatigue and eye fatigue. According to patient questioning and clinical exam, the Adverse Event Table will be completed (description, dates, severity, imputability, action,...).
Time Frame
1 day
Title
Security: device deficiencies
Description
By questioning the speech therapist - evaluation of deficiencies due to glasses: the device deficienciesTable will be completed (description, relation with adverse effect, taken measures,...).
Time Frame
1 day
Title
Child's satisfaction regarding reading fluency and comprehension
Description
Child interview with numeric scale (0-10) and yes/ no answer
Time Frame
1 day
Title
Speech therapist's satisfaction regarding Securirty, Performance and Usability of glasses
Description
speech therapist interview with 4 points - Likert scale (Very good, Good, Moderate, Bad)
Time Frame
1 day
10. Eligibility
Sex
All
Minimum Age & Unit of Time
8 Years
Maximum Age & Unit of Time
13 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Schooled in CM1, CM2 or 6ème,
French mother tongue,
For whom developmental dyslexia has been diagnosed by a health professional who specializes in this learning disorder,
With near vision, without optical correction, equivalent to P5 or better according to the Parinaud scale (distance: 30-40 cm),
Presenting an IQ ≥ 80 and ≤130 according to the WISC-V test performed by a psychologist,
For whom a written consent was obtained regarding his study participation.
Exclusion Criteria:
With medical history or presenting a neurological pathology,
Presenting a developmental disorder (autism, ADHD, ...),
Presenting hearing disorders,
Presenting an astigmatism of more than one uncorrected diopter,
Presenting other visual disorders,
Any other condition that, in the opinion of health professionals, could impair its ability to complete the study or could pose a significant risk.
Facility Information:
Facility Name
Dr Laurence Derieux
City
Caen
ZIP/Postal Code
14000
Country
France
Facility Name
Dr Luc-Marie Virlet
City
Faumont
ZIP/Postal Code
59310
Country
France
Facility Name
CHU Rennes
City
Rennes
ZIP/Postal Code
35000
Country
France
12. IPD Sharing Statement
Learn more about this trial
Evaluation of the Performance and Safety of the Atoldys/ Lexilens Glasses Developed to Improve the Reading of Dyslexic Subjects
We'll reach out to this number within 24 hrs